Skaana Management L.P. Intercept Pharmaceuticals, Inc. Call Options Transaction History

Skaana Management L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2023 May 15, 2023	SELL	$12.53 - $21.71 $226,793 - $392,951	-18,100 Reduced 99.45%	100 $1,000
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $211,302 - $293,202	18,200 New	18,200 $225,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Skaana Management L.P., based on Form 13F filings with the SEC.

Stay updated on Skaana Management L.P. with notifications on news.